REHAB-HF

Dr. Andy Dhaliwal presented the REHAB-HF Trial, which is a multicentre, randomized, controlled trial to evaluate the benefit of a tailored progressive rehabilitation intervention in older patients with a recent acute decompensated heart failure hospitalization . This trial was recently presented as a late-breaking trial at the ACC 2021 and simultaneously published in the NEJM on May 16th 2021.